1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Tuberculosis, MDR: new trials by email Literature Review of Tuberculosis, MDR trials Research Report on Tuberculosis, MDR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6) - Tuberculosis, MDR | Phase 3 | Active not recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 5832 | 2019-06-03 | 2025-06-15 |
Tuberculosis (1) · Tuberculosis, Multidrug-Resistant (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Mycobacterium Infections (1)
Isoniazid (1) · OPC-67683 (1) · Pyridoxine (1) · Vitamin B 6 (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
Botswana (1) · Brazil (1) · Haiti (1) · India (1) · Kenya (1) · Peru (1) · Philippines (1) · South Africa (1) · Tanzania (1) · Thailand (1) · Uganda (1) · Vietnam (1) · Zimbabwe (1)
Amita Gupta, MD, MHS (1) · Anneke Hesseling, MD, PhD (1) · Gavin Churchyard, MBBCh MMed FRCP FCP(SA) PhD (1) · Susan Swindells, MBBS (1)